Differential expression of two lck transcripts directed from the distinct promoters in HTLV‐I+ and HTLV‐I T‐cells

Kazuhiko Nakamura, Yasuhiro Koga, Hiroki Yoshida, Genki Kimura, Kikuo Nomoto

研究成果: ジャーナルへの寄稿記事

8 引用 (Scopus)

抄録

The lck gene encodes a lymphocyte‐specific tyrosine protein ktnase,p56lck, the expression of which is almost exclusive In T‐cells. The expression of lck in human T‐cell leukemia virus type I (HTLV‐1)‐transformed T‐cell lines is closely associated with interleukin‐2 (IL‐2) dependence for their growth. That is, IL‐2‐dependent HTLV‐1‐transformed cell lines contain the lck message abundantly as HTLV‐1‐negative T‐cell lines, whereas IL‐2‐Independent HTLV‐1‐transformed cell lines express either no or little lck mRNA, although they are derived from T‐cells. The lck gene contains 2 distinct promoters which direct 2 types of lck transcript with different S′ untranslated regions. In this study, we show that HTLV‐1‐transformed IL‐2‐dependent T‐cell lines contain the upstream promoter‐initiated lck transcript exclusively, in contrast to HTLV‐1‐negative transformed T‐cell lines which express the downstream promoter‐as well as the upstream promoter‐initiated lck transcript. In addition, lck mRNA disappears transiently in IL‐2‐dependent HTLV‐1‐transformed T‐cell lines after stimulation for T‐cell activation, which is also observed In peripheral blood T lymphocytes. These results indicate that the disappearance of lck mRNA in HTLV‐1‐transformed, IL‐2‐independent cell lines Is caused by a mechanism which down‐regulates the upstream promoter‐initiated lck transcript and this IL‐2‐independent state may represent a further “activated” condition of the IL‐2‐dependent state by the stimulation which mediates T‐cell activation.

元の言語英語
ページ(範囲)789-793
ページ数5
ジャーナルInternational Journal of Cancer
48
発行部数5
DOI
出版物ステータス出版済み - 1 1 1991

Fingerprint

Cell Line
Messenger RNA
Untranslated Regions
Genes
Tyrosine
Leukemia
Down-Regulation
Viruses
T-Lymphocytes
Growth
Proteins

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

これを引用

Differential expression of two lck transcripts directed from the distinct promoters in HTLV‐I+ and HTLV‐I T‐cells. / Nakamura, Kazuhiko; Koga, Yasuhiro; Yoshida, Hiroki; Kimura, Genki; Nomoto, Kikuo.

:: International Journal of Cancer, 巻 48, 番号 5, 01.01.1991, p. 789-793.

研究成果: ジャーナルへの寄稿記事

Nakamura, Kazuhiko ; Koga, Yasuhiro ; Yoshida, Hiroki ; Kimura, Genki ; Nomoto, Kikuo. / Differential expression of two lck transcripts directed from the distinct promoters in HTLV‐I+ and HTLV‐I T‐cells. :: International Journal of Cancer. 1991 ; 巻 48, 番号 5. pp. 789-793.
@article{7d504e64cf2742fcb43dd4285541b07a,
title = "Differential expression of two lck transcripts directed from the distinct promoters in HTLV‐I+ and HTLV‐I− T‐cells",
abstract = "The lck gene encodes a lymphocyte‐specific tyrosine protein ktnase,p56lck, the expression of which is almost exclusive In T‐cells. The expression of lck in human T‐cell leukemia virus type I (HTLV‐1)‐transformed T‐cell lines is closely associated with interleukin‐2 (IL‐2) dependence for their growth. That is, IL‐2‐dependent HTLV‐1‐transformed cell lines contain the lck message abundantly as HTLV‐1‐negative T‐cell lines, whereas IL‐2‐Independent HTLV‐1‐transformed cell lines express either no or little lck mRNA, although they are derived from T‐cells. The lck gene contains 2 distinct promoters which direct 2 types of lck transcript with different S′ untranslated regions. In this study, we show that HTLV‐1‐transformed IL‐2‐dependent T‐cell lines contain the upstream promoter‐initiated lck transcript exclusively, in contrast to HTLV‐1‐negative transformed T‐cell lines which express the downstream promoter‐as well as the upstream promoter‐initiated lck transcript. In addition, lck mRNA disappears transiently in IL‐2‐dependent HTLV‐1‐transformed T‐cell lines after stimulation for T‐cell activation, which is also observed In peripheral blood T lymphocytes. These results indicate that the disappearance of lck mRNA in HTLV‐1‐transformed, IL‐2‐independent cell lines Is caused by a mechanism which down‐regulates the upstream promoter‐initiated lck transcript and this IL‐2‐independent state may represent a further “activated” condition of the IL‐2‐dependent state by the stimulation which mediates T‐cell activation.",
author = "Kazuhiko Nakamura and Yasuhiro Koga and Hiroki Yoshida and Genki Kimura and Kikuo Nomoto",
year = "1991",
month = "1",
day = "1",
doi = "10.1002/ijc.2910480526",
language = "English",
volume = "48",
pages = "789--793",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Differential expression of two lck transcripts directed from the distinct promoters in HTLV‐I+ and HTLV‐I− T‐cells

AU - Nakamura, Kazuhiko

AU - Koga, Yasuhiro

AU - Yoshida, Hiroki

AU - Kimura, Genki

AU - Nomoto, Kikuo

PY - 1991/1/1

Y1 - 1991/1/1

N2 - The lck gene encodes a lymphocyte‐specific tyrosine protein ktnase,p56lck, the expression of which is almost exclusive In T‐cells. The expression of lck in human T‐cell leukemia virus type I (HTLV‐1)‐transformed T‐cell lines is closely associated with interleukin‐2 (IL‐2) dependence for their growth. That is, IL‐2‐dependent HTLV‐1‐transformed cell lines contain the lck message abundantly as HTLV‐1‐negative T‐cell lines, whereas IL‐2‐Independent HTLV‐1‐transformed cell lines express either no or little lck mRNA, although they are derived from T‐cells. The lck gene contains 2 distinct promoters which direct 2 types of lck transcript with different S′ untranslated regions. In this study, we show that HTLV‐1‐transformed IL‐2‐dependent T‐cell lines contain the upstream promoter‐initiated lck transcript exclusively, in contrast to HTLV‐1‐negative transformed T‐cell lines which express the downstream promoter‐as well as the upstream promoter‐initiated lck transcript. In addition, lck mRNA disappears transiently in IL‐2‐dependent HTLV‐1‐transformed T‐cell lines after stimulation for T‐cell activation, which is also observed In peripheral blood T lymphocytes. These results indicate that the disappearance of lck mRNA in HTLV‐1‐transformed, IL‐2‐independent cell lines Is caused by a mechanism which down‐regulates the upstream promoter‐initiated lck transcript and this IL‐2‐independent state may represent a further “activated” condition of the IL‐2‐dependent state by the stimulation which mediates T‐cell activation.

AB - The lck gene encodes a lymphocyte‐specific tyrosine protein ktnase,p56lck, the expression of which is almost exclusive In T‐cells. The expression of lck in human T‐cell leukemia virus type I (HTLV‐1)‐transformed T‐cell lines is closely associated with interleukin‐2 (IL‐2) dependence for their growth. That is, IL‐2‐dependent HTLV‐1‐transformed cell lines contain the lck message abundantly as HTLV‐1‐negative T‐cell lines, whereas IL‐2‐Independent HTLV‐1‐transformed cell lines express either no or little lck mRNA, although they are derived from T‐cells. The lck gene contains 2 distinct promoters which direct 2 types of lck transcript with different S′ untranslated regions. In this study, we show that HTLV‐1‐transformed IL‐2‐dependent T‐cell lines contain the upstream promoter‐initiated lck transcript exclusively, in contrast to HTLV‐1‐negative transformed T‐cell lines which express the downstream promoter‐as well as the upstream promoter‐initiated lck transcript. In addition, lck mRNA disappears transiently in IL‐2‐dependent HTLV‐1‐transformed T‐cell lines after stimulation for T‐cell activation, which is also observed In peripheral blood T lymphocytes. These results indicate that the disappearance of lck mRNA in HTLV‐1‐transformed, IL‐2‐independent cell lines Is caused by a mechanism which down‐regulates the upstream promoter‐initiated lck transcript and this IL‐2‐independent state may represent a further “activated” condition of the IL‐2‐dependent state by the stimulation which mediates T‐cell activation.

UR - http://www.scopus.com/inward/record.url?scp=0025823202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025823202&partnerID=8YFLogxK

U2 - 10.1002/ijc.2910480526

DO - 10.1002/ijc.2910480526

M3 - Article

VL - 48

SP - 789

EP - 793

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 5

ER -